Length-Time Bias — When Logic Wears a Disguise
Length-time bias occurs when screening programs preferentially detect slow-growing, less aggressive disease variants because they have a longer pre-symptomatic window during which screening can detect them. Fast-progressing cases cause symptoms and are detected clinically before screening, while slow cases are overrepresented in screened populations. This makes screened patients appear to have better outcomes, not because screening helps, but because their disease was less severe from the start.
Also known as: Sojourn time bias
How It Works
The biological aggressiveness of a disease directly affects both its detectability by screening and its natural prognosis, creating a strong confound that mimics a treatment effect.
A Classic Example
A cancer screening program shows that screened patients survive an average of 7 years post-diagnosis while unscreened patients survive only 3 years. However, this difference may simply reflect that screened patients had slow-growing tumors that would have been less dangerous regardless.
More Examples
A new screening program for thyroid cancer detects a large number of small, slow-growing tumors. Patients found through screening appear to have much better five-year survival rates than those diagnosed after symptoms appear. Critics note this likely reflects the fact that screening preferentially catches indolent tumors that would have remained harmless, not that the screening genuinely saves lives.
A workplace screening initiative for Type 2 diabetes shows that employees identified through routine testing live years longer post-diagnosis than those identified after symptoms emerge. However, the screened group predominantly has slow-progressing metabolic disease that would not have caused serious harm for decades, inflating the apparent benefit of the program.
Where You See This in the Wild
Length-time bias has complicated evaluation of prostate cancer (PSA) screening, where screened men appeared to do better largely due to detection of indolent tumors.
How to Spot and Counter It
Look for randomized controlled trials of screening programs that compare mortality rates in screened vs. unscreened populations. Survival time from diagnosis is an unreliable endpoint for screening efficacy.
The Takeaway
The Length-Time Bias is one of those reasoning errors that sounds perfectly logical at first glance. That's what makes it dangerous — it wears the costume of valid reasoning while smuggling in a broken conclusion. The best defense? Slow down and ask: does this conclusion actually follow from these premises, or am I just connecting dots that happen to be near each other?
Next time someone presents you with an argument that "just makes sense," check the structure. The feeling of logic is not the same as logic itself.